Author:
Golla Upendarrao,Joseph Deepthi,Tomar Raghuvir Singh
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45, doi: 10.1038/47412 (2000).
2. Mandal, P. et al. In Molecular mechanisms and physiology of disease: Implications for Epigenetics and Health (eds Nilanjana, Maulik & Tom, Karagiannis ) 113–126 (Springer: New York,, 2014).
3. de Nadal, E., Ammerer, G. & Posas, F. Controlling gene expression in response to stress. Nat Rev Genet 12, 833–845, doi: 10.1038/nrg3055 (2011).
4. Nebbioso, A., Carafa, V., Benedetti, R. & Altucci, L. Trials with ‘epigenetic’ drugs: An update. Molecular Oncology 6, 657–682, doi: 10.1016/j.molonc.2012.09.004 (2012).
5. Dokmanovic, M., Clarke, C. & Marks, P. A. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5, 981–989, doi: 10.1158/1541-7786.MCR-07-0324 (2007).